150 related articles for article (PubMed ID: 1246784)
1. Endocrine changes after diethylstilbestrol therapy. Effects on prostatic neoplasm and pituitary-gonadal axis.
Prout GR; Kliman B; Daly JJ; MacLaughlin RA; Griffin PP; Young HH
Urology; 1976 Feb; 7(2):148-55. PubMed ID: 1246784
[TBL] [Abstract][Full Text] [Related]
2. Effects of synthetic oral oestrogens in normal men and patients with prostatic carcinoma: lack of gonadotrophin suppression by chlorotrianisene.
Baker HW; Burger HG; De Kretser DM; Hudson B; Straffon WG
Clin Endocrinol (Oxf); 1973 Oct; 2(4):297-306. PubMed ID: 4797442
[No Abstract] [Full Text] [Related]
3. Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol.
Bruchovsky N; Goldenberg SL; Akakura K; Rennie PS
Cancer; 1993 Sep; 72(5):1685-91. PubMed ID: 7688656
[TBL] [Abstract][Full Text] [Related]
4. Effective long-term suppression of pituitary-gonadal axis in prostatic cancer by Zoladex (ICI 118,630).
Murphy GP; Greco J; Huben R
Urology; 1987 Nov; 30(5):482-3. PubMed ID: 2960064
[TBL] [Abstract][Full Text] [Related]
5. Changes in plasma levels of FSH, LH and testosterone during anti-androgenic hormone therapy for patients with prostatic cancer.
Shirai M; Matsuda S; Mitsukawa S; Nakamura M; Yonezawa K
Tohoku J Exp Med; 1974 Oct; 114(2):145-58. PubMed ID: 4612875
[No Abstract] [Full Text] [Related]
6. Medical castration with megestrol acetate and minidose of diethylstilbestrol.
Geller J; Albert J; Yen SS; Geller S; Loza D
Urology; 1981 Apr; 17(4 Suppl):27-33. PubMed ID: 6782738
[No Abstract] [Full Text] [Related]
7. Neonatal exposure to DES in BALB/c male mice: effects on pituitary-gonadal function.
Dalterio S; Bartke A; Steger R; Mayfield D
Pharmacol Biochem Behav; 1985 Jun; 22(6):1019-24. PubMed ID: 3927323
[TBL] [Abstract][Full Text] [Related]
8. Medical castration of males with megestrol acetate and small doses of diethylstilbestrol.
Geller J; Albert J; Yen SS; Geller S; Loza D
J Clin Endocrinol Metab; 1981 Mar; 52(3):576-80. PubMed ID: 6161942
[TBL] [Abstract][Full Text] [Related]
9. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
[TBL] [Abstract][Full Text] [Related]
10. Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens.
Boyns AR; Cole EN; Phillips ME; Hillier SG; Cameron EH; Griffiths K; Shahmanesh M; Feneley RC; Hartog M
Eur J Cancer (1965); 1974 Jul; 10(7):445-9. PubMed ID: 4376085
[No Abstract] [Full Text] [Related]
11. [Testosterone, FSH and LH level in the serum of patients with prostatic neoplasms, treated with female hormones].
Weidner W; Krause W; Pust R; Engstfeld J; Rothauge CF
Helv Chir Acta; 1978 Jul; 45(3):287-90. PubMed ID: 701064
[TBL] [Abstract][Full Text] [Related]
12. Plasma testosterone in patients receiving diethylstilbestrol.
Beck PH; McAnich JW; Goebel JL; Stutzman RE
Urology; 1978 Feb; 11(2):157-60. PubMed ID: 628992
[TBL] [Abstract][Full Text] [Related]
13. Hypogonadism following long-term treatment with diethylstilbestrol.
Wortsman J; Hamidinia A; Winters SJ
Am J Med Sci; 1989 Jun; 297(6):365-8. PubMed ID: 2500019
[TBL] [Abstract][Full Text] [Related]
14. Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone.
Atala A; Amin M; Harty JI
Urology; 1992 Feb; 39(2):108-10. PubMed ID: 1736500
[TBL] [Abstract][Full Text] [Related]
15. Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.
Warner B; Worgul TJ; Drago J; Demers L; Dufau M; Max D; Santen RJ
J Clin Invest; 1983 Jun; 71(6):1842-53. PubMed ID: 6408125
[TBL] [Abstract][Full Text] [Related]
16. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
Daane TA; Dignam WJ; Frankland MV; Simmer HH; Parlow AF
Am J Obstet Gynecol; 1973 Oct; 117(3):392-9. PubMed ID: 4729733
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen].
Hayashi T; Taki Y; Ikai K; Hiura M; Kiriyama T
Hinyokika Kiyo; 1987 Jul; 33(7):1035-42. PubMed ID: 2446483
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term effects of clomiphene citrate on the pituitary-testicular axis.
Santen RJ; Leonard JM; Sherins RJ; Gandy HM; Paulsen CA
J Clin Endocrinol Metab; 1971 Dec; 33(6):970-9. PubMed ID: 5135636
[No Abstract] [Full Text] [Related]
19. Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
Porcaro AB; Ghimenton C; Petrozziello A; Migliorini F; Romano M; Sava T; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C; Comunale L
Anticancer Res; 2011 Nov; 31(11):3913-20. PubMed ID: 22110219
[TBL] [Abstract][Full Text] [Related]
20. [Effects of chlormadinone acetate therapy on the pituitary-testicular system in prostatic cancer].
Nishimura R; Hosaka M; Mamiya N; Kimihira A; Konno M
Horumon To Rinsho; 1977 Sep; 25(9):1013-8. PubMed ID: 72621
[No Abstract] [Full Text] [Related]
[Next] [New Search]
